In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…
In a statement, Ford Motor Co said it will produce 50,000 ventilators over the next 100 days from its plant in Michigan in collaboration with General Electric’s healthcare unit. Following this, it can build 30,000 ventilators per month so as to treat patients afflicted with China’s Wuhan coronavirus. The simplified ventilator design, licensed by GE…
On Tuesday, Australian researchers disclosed, they have mapped the immune responses from one of country’s first coronavirus patients in an important step that closes the gap towards developing a vaccine and treatment for the Wuhan Coronavirus. While the bulk of those infected show only mild symptoms, nearly 20% of the patients are in critical conditions.…
The U.S. Department of Health and Human Services has partnered with Regeneron Pharmaceuticals Inc to develop a treatment for the coronavirus whose outbreak in China has killed hundreds of people in China alone. The drugmaker collaboration with the U.S. Department of Health and Human Services is the latest to join the race to develop a…
business-gurus.com 